Blood glucose monitoring devices for type 1 diabetes: a journey from the food and drug administration approval to market availability

Blood glucose monitoring devices for type 1 diabetes: a journey from the food and drug administration approval to market availability

Blood glucose monitoring constitutes a pivotal element in the clinical management of Type 1 diabetes (T1D), a globally escalating metabolic disorder. Continuous glucose monitoring (CGM) devices have demonstrated efficacy in optimizing glycemic control, mitigating adverse health outcomes, and augment...

Full description

Bibliographic Details
Main Authors:	Rahul Mittal, Nicole Koutras, Jonathan Maya, Joana R. N. Lemos, Khemraj Hirani
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-03-01
Series:	Frontiers in Endocrinology
Subjects:	type 1 diabetes glycemic control food and drug administration electrochemical sensors continuous glucose monitoring devices regulatory approval
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2024.1352302/full

Similar Items

Characteristics of pivotal clinical trials of FDA-approved endovascular devices between 2000 and 2018: An interrupted time series analysis
by: John T. Moon, et al.
Published: (2023-01-01)

Product Complexity and Strategic Alliance on Drug Approval
by: Taoyong Su, et al.
Published: (2021-05-01)

Administrative approval reform and the quality of economic development
by: Guangshun Zhu, et al.
Published: (2021-09-01)

Critical Analysis of Cardiovascular and Central Nervous System Fixed Dose Combinations Available in Indian Market
by: Krunal Prajapati, et al.
Published: (2016-12-01)

Analysis of the Regulatory Science Applied to a Single Portfolio of Eight Biosimilar Product Approvals by Four Key Regulatory Authorities
by: Beverly Ingram, et al.
Published: (2021-04-01)

Evaluation of the impact of orally administered carbohydrates on postprandial blood glucose levels in different pre-clinical models
by: Any de Castro Ruiz Marques, et al.

Non-invasive wearable electrochemical sensors for continuous glucose monitoring
by: Sameera Sh. Mohammed Ameen, et al.
Published: (2025-04-01)

Strength of clinical evidence supporting the United States Food and Drug Administration Accelerated Approvals from 2015 to 2022
by: Xiaofang Zhang, et al.
Published: (2024-12-01)

Drug lag for cardiovascular drug approvals in India compared with the US and EU approvals
by: Bhaven C. Kataria, et al.
Published: (2013-01-01)

Proposal of International Council for Harmonization (ICH) Guideline for the Approval of Biosimilars
by: Sarfaraz K. Niazi, et al.
Published: (2023-12-01)

From Drug Discovery to Drug Approval: A Comprehensive Review of the Pharmacogenomics Status Quo with a Special Focus on Egypt
by: Fadya M. Elgarhy, et al.
Published: (2024-07-01)

The United States Food and Drug Administration’s Platform Technology Designation to Expedite the Development of Drugs
by: Sarfaraz K. Niazi
Published: (2024-07-01)

Regulatory lessons from China’s COVID-19 vaccines development and approval policies
by: Jingshu Yang, et al.
Published: (2022-03-01)

U.S. Food and Drug Administration: Review for the Emergency Physician of Approval Process and Limitations
by: Nadia Zuabi, et al.
Published: (2016-11-01)

Blood Glucose Levels
by: Carlos Estela
Published: (2011-01-01)

DRUG LAG FOR ANTIMICROBIAL AGENTS: COMPARISON OF THE US, EU AND INDIA APPROVALS
by: Bhaven C Kataria, et al.
Published: (2012-09-01)

Regulatory Clearance and Approval of Therapeutic Protocols of Transcranial Magnetic Stimulation for Psychiatric Disorders
by: Gonçalo Cotovio, et al.
Published: (2023-07-01)

Transplanting islet cells can fix brittle diabetes. Why isn’t it available in the U.S.?
by: C. Ricordi, et al.
Published: (2019-10-01)

History of the discovery, development, and FDA-approval of buprenorphine medications for the treatment of opioid use disorder
by: Christian Heidbreder, et al.
Published: (2023-03-01)

An Embroidered Electrochemical Sensor to Measure Glucose Made with Commercially Available Textile Materials
by: Marc Martínez-Estrada, et al.
Published: (2025-02-01)

Assessment of the glycemic index of groats available on the Polish food market
by: Dorota Różańska, et al.
Published: (2020-03-01)

The effect of carbohydrate meals with high or low glycemic index on blood glucose concentration following prolonged strenuous exercise
by: J. Ziaolhagh, et al.
Published: (2012-03-01)

Food and Drug Administration (FDA) Approvals of Biological Drugs in 2023
by: Alexander C. Martins, et al.
Published: (2024-09-01)

Trends and Perspectives of Biological Drug Approvals by the FDA: A Review from 2015 to 2021
by: Alexander C. Martins, et al.
Published: (2022-09-01)

A review of new drugs approved by the food and drug administration in 2022
by: Arjun Swaminathan, et al.
Published: (2023-10-01)

Drugs approved by CDSCO, India in 2015
by: K Parushuram Naik1 , V Sai Lakshmi2 , J Jyothirmai3
Published: (2016-04-01)

Quantitative analysis of the factors that influence approval rates in subjects of undergraduate course at a public Education institution in southern Brazil
by: Fernando Elemar Vicente dos Anjos, et al.
Published: (2023-10-01)

Alignment in post-approval changes (PAC) guidelines in emerging countries may increase timely access to vaccines: An illustrative assessment by manufacturers
by: Nora Dellepiane, et al.
Published: (2020-12-01)

Evaluation of the Review Models and Approval Timelines of Countries Participating in the Southern African Development Community: Alignment and Strategies for Moving Forward
by: Tariro Sithole, et al.
Published: (2021-08-01)

Drug approval processes: A case study of rivaroxaban
by: Sally A Arif, et al.
Published: (2013-01-01)

Mesenchymal Stem Cell Therapies Approved by Regulatory Agencies around the World
by: Luis E. Fernández-Garza, et al.
Published: (2023-09-01)

The impact of a low glycemic index (GI) breakfast and snack on daily blood glucose profiles and food intake in young Chinese adult males
by: Bhupinder Kaur, et al.
Published: (2015-09-01)

Evidence of pre-approval clinical trial supporting the granted conditional approval for novel cancer drugs in China between 2015 and 2022Research in context
by: Xingxian Luo, et al.
Published: (2023-09-01)

The characteristics of postprandial glycemic response patterns to white rice and glucose in healthy adults: Identifying subgroups by clustering analysis
by: An-shu Liu, et al.
Published: (2022-10-01)

Regulatory histories of recently withdrawn ovarian cancer treatment indications of 3 PARP inhibitors in the US and Europe: lessons for the accelerated approval pathway
by: Mahnum Shahzad, et al.
Published: (2024-12-01)

Usefulness of continuous glucose monitoring of blood glucose control in patients with diabetes undergoing hemodialysis: A pilot study
by: Sua Lee, et al.
Published: (2023-04-01)

Currently Available Non-Balloon Devices
by: Hang Lak Lee
Published: (2018-09-01)

Real-world data: bridging the gap between clinical trials and practice
by: Brooke E. Wilson, et al.
Published: (2024-12-01)

Consensus Guidelines for the Use of Cyclin-Dependent Kinase (CDK) 4/6 Inhibitors in the Management of Hormone Receptor Positive (HR+ve), Her2−ve Early Breast Cancer (EBC)
by: Purvish M. Parikh, et al.

Gene Editing: The Regulatory Perspective
by: Sarfaraz K. Niazi
Published: (2023-10-01)